Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

610 results

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Orphan designations Remove Orphan designations filter

Medicine type Generic Remove Generic filter Exceptional circumstances Remove Exceptional circumstances filter Conditional approval Remove Conditional approval filter Accelerated assessment Remove Accelerated assessment filter Biosimilar Remove Biosimilar filter

Sort by

List item

Human medicine European public assessment report (EPAR): Aripiprazole Sandoz

aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 20/08/2015, , Revision: 9, Authorised, Last updated: 01/09/2022
List item

Human medicine European public assessment report (EPAR): Aripiprazole Zentiva

aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 25/06/2015, , Revision: 9, Authorised, Last updated: 26/08/2022
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Accord

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019, , Revision: 5, Authorised, Last updated: 12/05/2022
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide medac

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 17/09/2020, , Revision: 2, Authorised, Last updated: 26/04/2022
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Mylan

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 01/04/2020, , Revision: 4, Authorised, Last updated: 29/03/2023
List item

Human medicine European public assessment report (EPAR): Atazanavir Krka

atazanavir (as sulfate), HIV Infections
Date of authorisation: 25/03/2019, , Revision: 2, Authorised, Last updated: 07/06/2023
List item

Human medicine European public assessment report (EPAR): Atazanavir Mylan

atazanavir (as sulfate), HIV Infections
Date of authorisation: 22/08/2016, , Revision: 14, Authorised, Last updated: 17/05/2023
List item

Human medicine European public assessment report (EPAR): Atosiban SUN

atosiban (as acetate), Premature Birth
Date of authorisation: 31/07/2013, , Revision: 9, Authorised, Last updated: 09/02/2022
List item

Human medicine European public assessment report (EPAR): Atriance

nelarabine, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 22/08/2007, , , Revision: 26, Authorised, Last updated: 16/01/2023
List item

Human medicine European public assessment report (EPAR): ATryn

Antithrombin alfa, Antithrombin III Deficiency
Date of authorisation: 28/07/2006, , , Revision: 16, Withdrawn, Last updated: 02/07/2019
List item

Human medicine European public assessment report (EPAR): Aybintio

bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020, , , Revision: 7, Authorised, Last updated: 11/04/2023
List item

Human medicine European public assessment report (EPAR): Ayvakyt

Avapritinib, Gastrointestinal Stromal Tumors
Date of authorisation: 24/09/2020, , , , Revision: 7, Authorised, Last updated: 28/06/2023
List item

Human medicine European public assessment report (EPAR): Azacitidine Accord

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 13/02/2020, , Revision: 6, Authorised, Last updated: 29/03/2023
List item

Human medicine European public assessment report (EPAR): Azacitidine betapharm

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 24/03/2020, , Revision: 5, Authorised, Last updated: 13/02/2023
List item

Human medicine European public assessment report (EPAR): Azacitidine Mylan

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 27/03/2020, , Revision: 7, Authorised, Last updated: 05/10/2023
List item

Human medicine European public assessment report (EPAR): Bekemv

Eculizumab, Hemoglobinuria, Paroxysmal
Date of authorisation: 19/04/2023, , Revision: 1, Authorised, Last updated: 06/07/2023
List item

Human medicine European public assessment report (EPAR): Bemfola

follitropin alfa, Anovulation
Date of authorisation: 26/03/2014, , Revision: 10, Authorised, Last updated: 19/12/2022
List item

Human medicine European public assessment report (EPAR): Benepali

etanercept, Arthritis, Psoriatic; Arthritis, Rheumatoid; Psoriasis
Date of authorisation: 13/01/2016, , Revision: 21, Authorised, Last updated: 14/09/2023
List item

Human medicine European public assessment report (EPAR): Binocrit (updated)

epoetin alfa, Anemia; Kidney Failure, Chronic
Date of authorisation: 28/08/2007, , Revision: 22, Authorised, Last updated: 21/11/2023
List item

Human medicine European public assessment report (EPAR): Biograstim

filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008, , Revision: 8, Withdrawn, Last updated: 19/01/2017
List item

Human medicine European public assessment report (EPAR): Blenrep

belantamab mafodotin, Multiple Myeloma
Date of authorisation: 25/08/2020, , , , Revision: 7, Authorised, Last updated: 25/10/2023
List item

Human medicine European public assessment report (EPAR): Blitzima (updated)

rituximab, Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 13/07/2017, , Revision: 19, Authorised, Last updated: 29/11/2023
List item

Human medicine European public assessment report (EPAR): Bortezomib Accord

bortezomib, Multiple Myeloma
Date of authorisation: 20/07/2015, , Revision: 13, Authorised, Last updated: 25/03/2022
List item

Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi

bortezomib, Multiple Myeloma
Date of authorisation: 14/11/2019, , Revision: 5, Authorised, Last updated: 01/09/2021
List item

Human medicine European public assessment report (EPAR): Bortezomib Hospira

bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016, , Revision: 13, Authorised, Last updated: 09/10/2023